Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors
Katsumasa Nakajima(Boston Biomedical Research Institute), Bing Wang(Chinese Academy of Sciences), Aaron Kanter, Ryan S. Streeper(Gladstone Institutes), J.T. Brewer, Paul V. Szklennik, Thomas Daniels, Les McQuire, Young‐Shin Kwak, Myriam April(Novartis (United States)), Thomas A. Gilmore, Michael H. Serrano‐Wu(Broad Institute), Jingzhou Li, James Thompson(University Hospital Southampton NHS Foundation Trust), Monish Jain, Cornelia J. Forster(Novartis (United States))
Cited by 5
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes
|Journal of Lipid Research|2011|340
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196